Pfizer 2Q12 2Q Revenues: $15.0 billion (-9%) 2Q Earnings: $3.5 billion (+25%) YTD Revenues: $29.9 billion (-8%) YTD Earnings: $5.0 billion (+4%) Comments: U.S. revenues fell 15% to $5.7 billion, due primarily to the loss of patent protection for Lipitor. International revenues fell 5% to $9.3 billion, mainly due to currency exchange rates. Drug revenues fell 10% overall to $13.1 billion, including a 3% drop from exchange rates. The Primary Care segment, which includes Lipitor, took a 31% tu...